ST-246 FDA Approval Status
FDA Approved: No
Brand name: ST-246
Company: SIGA Technologies, Inc.
Treatment for: Exposure to Smallpox Virus
ST-246 is an orally active, smallpox antiviral in development to treat individuals exposed to the smallpox virus in the event of an outbreak.
Development timeline for ST-246
| Date | Article |
|---|---|
| Apr 4, 2008 | SIGA Initiates Manufacture of ST-246 NDA Registration Batches |
| Mar 24, 2008 | SIGA Files Application Supporting Emergency Use Approval for ST-246 |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.